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Abstract
Introduction Fracture risk assessment algorithm (FRAX)
is the most validated method available to predict fracture
risk. Its use is restricted due to limited availability of Dual
Energy X-ray Absorptiometry (DXA). FRAX has the option
of assessing fracture risk without bone mineral density
(BMD) data.
Objectives To assess the ability of Sri Lankan FRAX
algorithm without BMD input in evaluating fracture risk.
The possibility of replacing the BMD input with Quan-
titative Ultrasound (QUS) data of radius in calculating
fracture risk also assessed.
Methods Data of clinical risk factors associated with
fractures were collected from community dwelling
postmenopausal women (n=339). DXA scans were
performed in all subjects and QUS scans (in radius)
were performed in a randomly selected sample (n=207).
Ten-year risks of major osteoporotic fracture (MOFR)
and hip fracture (HFR) were calculated with BMD, without
BMD (FRAX-FN0) and with QUS T score instead of BMD
(FRAX-UST).
Results and conclusion Nearly 35.7% had high risk of
fractures. FRAX-FN0 had 79.2% sensitivity, 80.1%
specificity, 68.8% positive predictive value (PPV) and
87.4% negative predictive value (NPV). FRAX-UST
showed 78.4% sensitivity, 70% specificity, 59.8% PPV
and 85% NPV. ROC AUCs were above 0.80 in both FRAX-
FN0 and FRAX-UST. The standard errors of estimate
(SEE) were less in FRAX-FN0 (3.96 and 2.76 for MOFR-
FN0 and HFR-FN0 respectively) compared to FRAX-UST
(6.13 and 4.83 for MOFR-UST and HFR-UST, res-
pectively). In conclusion, Sri Lankan FRAX without BMD
is an acceptable alternative in areas with restricted DXA
facility. Radial QUS data cannot be used as a substitute
to FN-BMD in Sri Lankan FRAX.
Introduction
Osteoporosis which is characterized by low bone
mineral density (BMD) and microarchitectural deterioration
is associated with increased fracture risk especially in
elderly [1,2]. According to the International Osteoporosis
Foundation,  osteoporosis leads to  more than 8.9 million
fractures worldwide, annually, and every 1 in 3 women
and 1 in 5 men are at risk of osteoporotic fracture, during
the lifetime [3]. Fracture incidence varies in different
populations and the rates are expected to increase
continuously as the global population turn older. The USA
experienced two million osteoporotic fractures in 2005 and
this figure is projected to reach three million in 2025 [4,5].
Elderly population in Asia is rapidly expanding and in
2050, 50% of total hip fractures would be seen in the Asian
region [6-8].
In order to reduce osteoporotic fractures, high risk
patients need to be detected and intervened early. Though
there are many tools available to assess fracture risk,
FRAX (Fracture Risk Assessment Tool), is the most
validated and widely used. It has been developed based
on clinical risk factors which have proven associations
with low bone density or occurrence of fractures by large
epidemiological studies [9]. FRAX algorithm which can
be applied to both men and women between 40-90 years
estimates the 10-year probability of both hip and major
osteoporotic fractures [9].
Despite the wide use, FRAX has major limitations.
FRAX needs femoral neck (FN) BMD assessed by either
Dual Energy X-ray Absorptiometry (DXA) or Quantitative
Computed Tomography (QCT) as an input variable thus
restricting its full application in countries with limited
facilities. As an alternative, attempts have been made to
estimate fracture risk without BMD data. Some studies
have shown that the forecast of 10-year fracture probability
with and without BMD is comparable [10-12]. However,
some studies have shown conflicting results [13-15]. It is
intuitive to think that the non-inclusion of BMD is
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compensated, at least partly, by inclusion of other clinical
risk factors (CRF) which are independent determinants of
BMD. However, the ability of CRFs to make this
compensation is unclear.
 Though DXA is the gold standard in assessing BMD
[16-18] quantitative ultrasound (QUS) is used to detect
bone strength and fracture risk, particularly in less
resourceful settings [19,20]. QUS is cheaper, portable and
free of ionized radiation, hence can be used in many
situations [21,22]. QUS does not measure BMD but it
captures bone texture and generates measures such as
Speed of Sound (SOS) and Broadband Ultrasound
Attenuation (BUA). If QUS data, especially T-Score, can
be used instead of femoral neck BMD in assessing fracture
risk, it can partly overcome the restricted use of FRAX
owing to the lack of DXA facility in many countries.
However, we were unable to find studies examining the
possibility of replacing BMD with QUS data in FRAX.
The objective of this study was to assess the impact
of non-inclusion of femoral neck BMD on the fracture risk
evaluation based on Sri Lankan FRAX algorithm. Further,
we assessed the possibility of replacing the femoral neck
BMD input with US data in calculating fracture risk.
Materials and methods
This cross-sectional study was conducted in Galle
district in southern Sri Lanka. Ethical approval was
obtained from the Ethical Review Committee of  Faculty of
Medicine, University of Ruhuna prior to data collection
(Ref  No. 09.03.2016:3.3).
Three Pradeshiya Sabha Divisions (intermediate
administrative unit) were selected from Galle district in
random manner. Two Gramasewa divisions (the smallest
administrative unit) from each Pradeshiya Sabha division
were selected, randomly, for data collection. Posters
were displayed in public places of selected Gramasewa
divisions to inform the public about the research.
Community-dwelling postmenopausal women who
voluntarily filled the ‘expression of interest form’ were
invited to take part in the study. Women with chronic
diseases of liver, kidney, heart, lungs or endocrine organs
were excluded. Furthermore, women on medications that
could affect vitamin D metabolism (hormonal con-
traceptives, diuretics, vitamin D supplementations) were
also excluded from the study sample.
All participants (n=339) were educated about the
research and their written consent was obtained before
enrolling into the study. Data were collected by inter-
viewing them individually using a content validated
datasheet. Weight and height were measured adhering to
the standard protocols. Ultrasound bone scan (Sunlight
Mini Omni, Israel) of the radius of the non-dominant side
was performed in 207 randomly selected participants. All
US scans were done by one trained investigator adhering
to manufacturer’s protocol and the machine was calibrated
on each day prior to scanning. BMDs of the total spine
(L1-L4), femoral neck and total hip were measured with
DXA scan (Hologic Discovery W, Hologic Inc, Bedford,
MA, USA). All the scans were performed by a trained
technician adhering to manufacturer’s protocol and the
machine was calibrated on each day prior to scanning.
Women were categorized as osteoporosis, osteopenia or
normal, based on the T scores adhering to the WHO
criteria [23,24].
Both major osteoporotic fracture risk (MOFR) and
hip fracture risk (HFR) were calculated using the Sri Lankan
FRAX tool (SL-FRAX). Calculations were modified and
done twice; (i) without femoral neck BMD (FRAX-FN0),
(ii) and with US T-score in place of femoral neck T-score
(FRAX-UST).
The DXA scanner generated FRAX values which
included femoral neck BMD (FRAX-A) were considered
the reference standard. MOFR11% and HFR 3% were
taken as intervention thresholds (25) and participants were
categorized to high or low risk based on these cut-off
values.
Statistical Analysis
MOFR and HFR of modified methods were compared
with MOFR-A and HFR-A, respectively by paired t-test
to assess differences. We also assessed the sensitivity,
specificity, PPV and NPV of modified FRAX tools with
regards to their ability to discriminate between high and
low risk women compared to FRAX-A. Bland-Altman plots
were constructed to determine the agreement between
estimated and actual fracture probabilities. Receiver
operating characteristic (ROC) curves were drawn and area
under the curves (AUC) were determined in order to assess
the fracture risk prediction of the new models based on
actual fracture risk categorization by FRAX-A. Further,
regression analyses were conducted for each modified
FRAX tool to estimate how they predicted FRAX-A values.
Standard Error of the Estimate (SEE) was considered in
assessing the goodness of the fit and the accuracy of the
predictions.
Results
The study sample included 339 postmenopausal
women and their descriptive data are shown in Table 1.
The prevalence of osteoporosis was 74.3% in the study
sample and another 21.5% had osteopenia.
Table 2 shows the mean differences between the
FRAX-A and modified FRAX outputs. MOFR-FN0 and
HFR-FN0 showed the lowest mean differences when
compared with MOFR-A and HFR-A, respectively. In
contrast, MOFR-UST and HFR-UST showed com-
paratively higher mean differences.
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Variable Mean (SD)/ n (%)  Range
Age (years) 63.8 (9.3) 40-87
Body weight (kg) 51.7 (0.4) 24.0-85.8
Height (cm) 147.8 (5.6) 130.0-163.0
BMI (kg/m2) 23.6 (4.4) 12.7-37.7
Femoral neck BMD (g/cm2) 0.634 (0.129) 0.237-1.209
Ultrasound SOS (m/s) 3946 (189) 3475-4790
Previous fracture 53 (15.6%)
Parent fractured hip 14 (4.1%)
Current smoking 0
Glucocorticoids use 76 (22.4%)
Rheumatoid arthritis 69 (20.3%)
Secondary osteoporosis 6 (1.8%)
Alcohol 3 or more units/day 0
Table 1.  Descriptive characteristics of the study sample
In the assessment of fracture risk, FRAX-A detected 35.7% of study participants to be in the high-risk category
based on the intervention thresholds adopted while FRAX-FN0 showed 41% to have a high fracture risk. The percentage
of females categorised into low and high risk groups based on the performance of each FRAX model is given in table 3.
FRAX tool used 10-year fracture Intervention % at high risk of % of women
probability threshold score  fractures needed treatments
FRAX-A MOFR-A High risk 11 26.8 35.7
HFR-A High risk 3 35.7
FRAX-FN0 MOFR-FN0 High risk 11 28.6 4 1
HFR-FN0 High risk 3 4 1
FRAX-UST MOFR-UST High risk 11 42.5 47.8
HF-UST High risk 3 46.9
Table 3. Ability of FRAX tools to identify high fracture risk
FRAX-A – Absolute Fracture risk assessment tool, MOFR-A – Absolute major osteoporotic fracture risk. HFR-A – Absolute hip fracture risk. FRAX-FN0- FRAX without
bone mineral density, MOFR-FN0 – major osteoporotic fracture risk calculated without bone mineral density. HFR-FN0 – hip fracture risk calculated without bone mineral
density. FRAX-UST- FRAX with ultrasound T score, MOFR-UST – major osteoporotic fracture risk calculated with ultrasound T score. HFR-UST- hip fracture risk
calculated with ultrasound T score.
Table 2. Comparison of modified FRAX outputs with FRAX-A
Pair of variables compared Mean SD 95% Confidence Interval of
difference the mean difference
Lower Upper
Pair 1 MOFR-A- MOFR-FN0 -0.11 5.63 -0.72 0.49
Pair 2 MOFR-A- MOFR-UST -4.86 12.39 -6.57 -3.15
Pair 3 HFR-A- HFR-FN0 -0.37 4.98 -0.90 0.16
Pair 4 HFR-A - HFR-UST -4.22 11.69 -5.83 -2.60
SD-Standard deviation, MOFR-A – Absolute major osteoporotic fracture risk. HFR-A – Absolute hip fracture risk. MOFR-FN0 – major osteoporotic fracture risk
calculated without bone mineral density. HFR-FN0 – hip fracture risk calculated without bone mineral density. MOFR-UST – major osteoporotic fracture risk calculated
with ultrasound T score. HFR-UST- hip fracture risk calculated with ultrasound T score.
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FRAX-FN0 showed high sensitivity (79.2%) and
specificity (80.1%) in detecting women with high fracture
risk. Further, PPV and NPV of FRAX-FN0 were 68.8%
and 87.4%, respectively. Though, FRAX-UST had high
sensitivity (78.4%), its specificity was low (70%) indicating
high possibility of misclassifying fracture risk. Further-
more, FRAX-UST had low PPV (59.8%) although its NPV
was 85%.
Bland-Altman plots (Figures 1-4) showed the
agreement between the actual and estimated fracture risk
probabilities. MOFR-FN0 and HFR-FN0 showed good
agreement with respective actual values. The agreement
Figure 1. Bland Altman plot of MOFR-A
and MOFR-FN0
Figure 4.  Bland Altman plot of HFR-A and
HFR-UST.
of MOFR-UST and HFR-UST with the respective actual
values were lost at higher estimated values.
Figures 5 and 6 show the ROC curves for FRAX-FN0
and FRAX-UST, respectively. AUC of MOFR-FN0 was
0.88 (95% CI 0.85 to 0.92, p<0.001) and HFR-FN0 was 0.89
(95% CI 0.85 to 0.92, p<0.001). The corresponding values
for MOFR-UST and HFR-UST were 0.85 (95% CI 0.79 to
0.89, p<0.001) and 0.83 AUC (95% CI 0.77 to 0.88, p<0.001)
respectively. Comparison showed that AUCs of FRAX-
FN0 (0.88 of MOFR and 0.89 of HFR) were significantly
higher (p<0.001) than those of FRAX-UST (0.85 of MOFR
and 0.83 of HFR).
Figure 3. Bland Altman plot of MOFR-A
and MOFR-UST.
Figure 2. Bland Altman plot of HFR-A
and HFR-FN0
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Figure 6. ROC curve for MOFR-UST and
HFR-UST.
Figure 5. ROC curve for MOFR-FN0 and
HFR-FN0
Age Body weight BMI
r P value         r   P value       r    P value
MOFR-A 0.47 <0.001 -0.37 <0.001 -0.29 <0.001
HFR-A 0.28 <0.001 -0.39 <0.001 -0.34 <0.001
MOFR-FN0 0.68 <0.001 -0.39 <0.001 -0.32 <0.001
HFR-FN0 0.60 <0.001 -0.45 <0.001 -0.42 <0.001
MOFR-UST 0.35 <0.001 -0.27 <0.001 -0.22 <0.001
HFR-UST 0.22 <0.001 -0.26 <0.001 -0.22 <0.001
  Table 5. Correlations of FRAX-FN0 and FRAX-UST with clinical risk factors
MOFR-FN0 and HFR-FN0 showed strong correlations with age, body weight and BMI (p<0.001 for all associations,
Table 5).
Model r R2 SEE P value
MOFR-FN0 0.76 0.58 3.96 <0.001
HFR-FN0 0.62 0.38 2.76 <0.001
MOFR-UST 0.58 0.34 6.13 <0.001
HFR-UST 0.48 0.23 4.83 <0.001
r– correlation coefficient, R2 – coefficient of determination, SEE – standard error of estimate MOFR-FN0 – major osteoporotic fracture risk calculated
without bone mineral density. HFR-FN0 – hip fracture risk calculated without bone mineral density. MOFR-UST – major osteoporotic fracture risk
calculated with ultrasound T score. HFR-UST – hip fracture risk calculated with ultrasound T score.
Table 4. Regression analysis comparing modified fracture probabilities against
reference standard
P<0.001 for all the associations. r – correlation coefficient, MOFR-A – Absolute major osteoporotic fracture risk. HFR-A – Absolute hip fracture risk. MOFR-FN0 – major
osteoporotic fracture risk calculated without bone mineral density. HFR-FN0 – hip fracture risk calculated without bone mineral density. MOFR-UST – major osteoporotic
fracture risk calculated with ultrasound T score. HFR-UST – hip fracture risk calculated with ultrasound T score.
MOFR-FN0 – major osteoporotic fracture risk calculated without bone mineral
density. HFR-FN0 – hip fracture risk calculated without bone mineral density.
MOFR-UST – major osteoporotic fracture risk calculated with ultrasound T score.
HFR-UST – hip fracture risk calculated with ultrasound T score.
The results of the regression analyses are shown in Table 4. Compared to fracture probabilities estimated with UST,
fracture probabilities estimated without BMD showed greater r and R2 and lesser measurement differences (SEE).
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Discussion
Many countries have developed own FRAX models
using national data on the assumption that country-
specific algorithms suit the local populations best. The
accuracy of a particular FRAX model depends on the
information that was used to build the model. Some
countries such as Sri Lanka used data of a surrogate
population to build the model.
This study compared Sri Lankan FRAX model with
and without BMD data in predicting the 10-year
probability of hip and major osteoporotic fractures among
postmenopausal women. Furthermore, we assessed the
validity of using US bone scan data (T-score of radius)
instead of femoral neck BMD in SL-FRAX to predict
fracture probabilities. Our data demonstrate that SL-FRAX
without BMD input can be an alternative for clinicians
working in places with no access to DXA facility. Inclusion
of US T-score in the calculation did not improve the
fracture risk predictability among this group of women.
When the femoral neck BMD was included in the
calculation, 35.7% of the study participants had high
fracture risk requiring pharmacological interventions. The
SL-FRAX without BMD input slightly overestimated this
value (41%). However, the strong correlation between
FRAX-FN0 and FRAX-A proves that fracture risk
prediction by FRAX without BMD coincide with fracture
risk predicted with BMD. In previous studies, non-
inclusion of BMD caused both overestimation and
underestimation of the fracture risk [13-15]. FRAX without
BMD has underdiagnosed both major osteoporosis and
hip fracture risks in a Spanish women population.
However, they did not use a FRAX tool specific for Spanish
population in their study [13]. Egsmose et al.  revealed
that FRAX without BMD overestimated the fracture risk
in a group of postmenopausal women who had suffered
distal forearm fractures [14]. A similar observation was
seen among patients with rheumatoid arthritis in the UK
[15]. Gadam et al., however, found 84% identical fracture
risk prediction by FRAX with and without BMD in a
multiethnic study sample in the USA [11]. Further, Turkish
postmenopausal women with osteopenia showed 93%
agreement between FRAX with and without BMD in
assessing HFR [12]. A similar study in Canada showed
that, Canadian FRAX tool without BMD is a good
predictor of fracture risk in both men and women [26]. The
evidence show that, there is a range of 76 to 90 % agreement
between FRAX scores determined with and without
BMD [12].
Our data does not support the idea of substituting
DXA derived BMD with QUS data in FRAX calculations.
The FRAX-UST showed comparatively weak associations
with FRAX-A. In Sri Lanka, QUS is used in areas where
DXA is not readily available as it is relatively cheap and
easy to use. QUS uses ultrasound waves to assess the
bone quality and therefore the principles used in QUS are
different from DXA. Furthermore, the utility of  QUS in the
field of osteoporosis is uncertain [27,28].
We observed a considerable overestimation of
fracture risk by FRAX-UST (47.8% vs 35.7%). The US
bone scans are technologically different and the generated
outcome largely depend on the site measured and the
instrument used [29-31]. In addition the soft tissue layers
covering the bone, its composition and thickness could
interfere the precision of QUS measurements [32-35].
Both FRAX-FN0 and FRAX-UST had more than 80%
AUC and showed their ability to discriminate high and
low risk patients. Of them, FRAX-FN0 had greater AUC
compared to FRAX-UST. The SEE produced by regression
analysis is a measure of deviation of residuals from
regression line with higher values indicating higher
deviation. In our analysis, SEE of MOFR-FN0 and HFR-
FN0 showed a lesser variation when compared with similar
values of QUS. In contrast, MOFR-UST and HFR-UST
had comparatively higher SEE showing higher deviation
from MOFR-A and HFR-A.
Age, body weight and BMI are predominant clinical
risk factors of osteoporotic fractures. Probabilities of both
MOFR and HFR calculated without BMD showed stronger
correlations with age, body weight and BMI when
compared with FRAX-UST. It implies that US SOS of the
radius does not reflect the age-related changes in BMD.
In support of this, studies have shown poor agreement
between radial US and DXA technics and thus suggested
radial QUS is not a good alternative to DXA [27,31,36]. On
the other hand, QUS of calcaneus showed good
correlations with DXA BMD [28,37].
This study has some limitations. Since we have no
electronic medical record system in Sri Lanka, we
sometimes have to depend on the information provided
by the patients about clinical risk factors to calculate
FRAX. We, however, verified the information using
personal health records. Further, the QUS scanning device
we used could measure only the SOS and not the BUA.
SOS and BUA together produce a parameter ‘Stiffness
Index’ which more precisely describe the quality of the
bone.
In conclusion, we suggest that Sri Lankan FRAX
tool without BMD provides a reasonable alternative to
assess fracture risk of postmenopausal women in places
where DXA facility is not readily available. This will help
to narrow down the current care gap in which many
subjects with high fracture risk are not recognized and
remain untreated. Radial QUS data cannot be used in FRAX
in place of BMD to assess fracture risk.
Acknowledgements
Authors are thankful to the study participants and
the staff of DEXA scanning unit, Teaching Hospital
Karapitiya, Galle. Further we acknowledge the financial
23Vol. 64, No. 1, March 2019
Original article
support by the postgraduate research grants of the
University Grants Commission of Sri Lanka and the
University of Wolverhampton, UK.
Conflicts of interests
The authors declare that there are no conflicts of
interest.
Declaration
The authors declare that, this research paper was
not published or not under consideration in part or as a
whole in any other journal or a proceeding.
References
1. Choi EJ, Kim SA, Kim NR, Rhee JA, Yun YW, Shin MH.
Risk Factors for Falls in Older Korean Adults: The 2011
Community Health Survey. J Korean Med Sci  2014; 29:
1482.
2. Lee S, Choi MG, Yu J, et al. The effects of the Korean
reference value on the prevalence of osteoporosis and the
prediction of fracture risk. BMC Musculoskelet Disord  2015;
16: 1-13.
3. International Osteoporosis Foundation. Facts and statistics
[Internet]. IOF international. 2017 [cited 2018 Jul 17].
Available from: https://www.iofbonehealth.org/facts-
statistics#category-14
4. Ettinger B, Black DM, Dawson-Hughes B, Pressman AR,
Melton LJ. Updated fracture incidence rates for the US
version of FRAX®. Osteoporos Int 2010; 21: 25-33.
5. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King
A, Tosteson A. Incidence and economic burden of
osteoporosis-related fractures in the United States, 2005-
2025. J Bone Miner Res 2007; 22: 465-75.
6. Cooper C, Campion G, Melton LJ. Hip fractures in the
elderly: A world-wide projection. Osteoporos Int 1992; 2:
285-9.
7. Gullberg B, Johnell O, Kanis JA. World-wide projections
for hip fracture. Osteoporos Int 1997; 7: 407-13.
8. Cheung EYN, Tan KCB, Cheung C-L, Kung AWC.
Osteoporosis in East Asia: Current issues in assessment
and management. Osteoporos Sarcopenia 2016; 2: 118-33.
9. Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O,
Borgström F. Development and use of FRAX® in
osteoporosis. Osteoporos Int 2010; 21: 407-13.
10. Shenoy S, Madduri S, Cherqaoui R, Nunlee-Bland G. 10-
year frax calculations with and without femoral neck bone
mineral density in African American patients with type 2
diabetes. Endocr Rev 2014; 35.
11. Gadam RK, Schlauch K, Izuora KE. Frax Prediction without
BMD for Assessment of Osteoporotic Fracture Risk.
Endocr Pract 2013; 19: 780-4.
12. Sarikaya NO, Yavasi SK, Tan G, et al. Agreement between
FRAX scores calculated with and without bone mineral
density in women with osteopenia in Turkey. Clin
Rheumatol 2014; 33: 1785-9.
13. Azagra R, Roca G, Encabo G, et al. FRAX® tool, the WHO
algorithm to predict osteoporotic fractures: The first
analysis of its discriminative and predictive ability in the
Spanish FRIDEX cohort. BMC Musculoskelet Disord
2012; 13.
14. Egsmose EL, Birkvig M, Buhl T, Madsen OR. FRAX
fracture risk in women with a recent fracture of the distal
forearm: agreement between assessments with and without
bone mineral density and impact of measurement side in
the individual patient. Clin Rheumatol 2015; 34: 1265-72.
15. Klop C, De Vries F, Bijlsma JWJ, Leufkens HGM, Welsing
PMJ. Predicting the 10-year risk of hip and major
osteoporotic fracture in rheumatoid arthritis and in the
general population: An independent validation and update
of UK FRAX without bone mineral density. Ann Rheum
Dis 2016; 75: 2095-100.
16. Alquaiz AM, Kazi A, Tayel S, et al. Prevalence and factors
associated with low bone mineral density in Saudi women:
A community based survey. BMC Musculoskelet Disord
2014; 15.
17. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton
LJ, Khaltaev N. A reference standard for the description of
osteoporosis. Bone 2008; 42: 467-75.
18. Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar
A, Serrano-Arias M, Cannata-Andía JB. Prevalence of
osteoporosis in men and determinants of changes in bone
mass in a non-selected Spanish population. Osteoporos Int
2005; 16: 603-9.
19. Nayak S, Olkin I, Liu H, Grabe M, Gould MK, Allen IE.
Annals of Internal Medicine Review Meta-Analysis?:
Accuracy of Quantitative Ultrasound for Identifying
Patients with Osteoporosis. Ann Intern Med 2006; 144:
832-41.
20. Siribaddana SH, Kovas Y, Fernando DJS. Quantitative
ultrasound of bone and calcium intake in suburban males in
Sri Lanka. Int J Rheum Dis 2008; 11: 407-13.
21. Marín F, González-Macías J, Díez-Pérez A, Palma S,
Delgado-Rodríguez M. Relationship between bone
quantitative ultrasound and fractures: A meta-analysis. J
Bone Miner Res 2006; 21: 1126-35.
22. McCloskey EV, Kanis JA, Odén A, et al. Predictive ability
of heel quantitative ultrasound for incident fractures: an
individual-level meta-analysis. Osteoporos Int 2015; 26:
1979-87.
23. Kanis JA, McCloskey EV, Harvey NC, Johansson H, Leslie
WD. Intervention thresholds and the diagnosis of
osteoporosis. J Bone Miner Res 2015; 30: 1747-53.
24. Kanis JA, Melton LJ, Christiansen C, Johnston CC,
Khaltaev N. The diagnosis of osteoporosis. J Bone Miner
Res 1994; 9: 1137-41.
24 Ceylon Medical Journal
Original article
25. Lekamwasam S. Sri Lankan FRAX model and country-
specific intervention thresholds. Arch Osteoporos 2013; 8.
26. Fraser LA, Langsetmo L, Berger C, et al. Fracture prediction
and calibration of a Canadian FRAX® tool: A population-
based report from CaMos. Osteoporos Int 2011; 22: 829-37.
27. Williams JE, Wilson CM, Biassoni L, Suri R, Fewtrell MS.
Dual energy x-ray absorptiometry and quantitative
ultrasound are not interchangeable in diagnosing abnormal
bones. Arch Dis Child 2012; 97: 822-4.
28. Hashmi FR, Elfandi KO. Heel ultrasound scan in detecting
osteoporosis in low trauma fracture patients. Orthop Rev
2016; 8: 61-3.
29. Hans D, Krieg MA. Quantitative ultrasound for the detection
and management of osteoporosis. Salud Publica Mex 2009;
51: S25-37.
30. Krieg MA, Barkmann R, Gonnelli S, et al. Quantitative
Ultrasound in the Management of Osteoporosis: The 2007
ISCD Official Positions. J Clin Densitom 2008; 11:
163-87.
31. Chong KH, Poh BK, Jamil NA, Kamaruddin NA, Deuren-
berg P. Radial quantitative ultrasound and dual energy
X-ray absorptiometry: Intermethod agreement for bone
status assessment in children. Biomed Res Int 2015; 2015.
32. Malo MKH, Karjalainen JP, Isaksson H, Riekkinen O,
Jurvelin JS, Töyräs J. Numerical Analysis of Uncertainties
in Dual Frequency Bone Ultrasound Technique. Ultrasound
Med Biol 2010; 36: 288-94.
33. Riekkinen O, Hakulinen MA, Timonen M, Töyräs J,
Jurvelin JS. Influence of overlying soft tissues on trabecular
bone acoustic measurement at various ultrasound
frequencies. Ultrasound Med Biol 2006; 32: 1073-83.
34. Stein EM, Rosete F, Young P, et al. Clinical assessment of
the 1/3 radius using a new desktop ultrasonic bone
densitometer. Ultrasound Med Biol 2014; 8: 1385-95.
35. Eliakim A, Nemet D, Wolach B. Quantitative ultrasound
measurements of bone strength in obese children and
adolescents. J Pediatr Endocrinol Metab 2001; 14: 159-64.
36. Khan KM, Sarafoglou K, Somani A, Frohnert B, Miller BS.
Can ultrasound be used to estimate bone mineral density in
children with growth problems? Acta Paediatr Int J Paediatr
2013; 102.
37. Rajendran K, Suthakaran PK, Devayani L, et al. Evaluation
of osteoporosis using calcaneal QUS and FRAX score as a
screening tool in a semi urban tertiary care hospital of South
India. Int J Adv Med 2015; 2: 341-5.
